VEGFA and glioblastoma: This oral alkylating agent induces DNA damage that results in apoptosis and reduces the expression of vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMP).1,2 However, the effectiveness of TMZ is limited by its toxicity3 and the fact that GBM tumors develop resistance within 7-10 months of treatment.4